65 completed. 65 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 65 | Completed 65 |
Follow Prostatic Neoplasms: new trials by email Literature Review of Prostatic Neoplasms trials Research Report on Prostatic Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy flotufolastat (18F), piflufolastat (18F) - Prostate Cancer | Phase 4 | Completed | Blue Earth Diagnostics | 62 | 2024-12-04 | 2026-07-13 |
| PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer Piflufolastat F 18 Intravenous Solution [PYLARIFY] - Prostate Cancer | Phase 4 | Completed | Lantheus Medical Imaging | 279 | 2024-02-08 | 2026-11-17 |
| Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain Self-Administered Nitrous Oxide, Oxygen - Prostate Disease, Malignancy | Phase 4 | Completed | Beth Israel Deaconess Medical Center | 143 | 2021-12-12 | 2024-01-30 |
| A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC) Apalutamide, Placebo, Androgen-deprivation Therapy (ADT) - Prostatic Neoplasms | Phase 4 | Completed | Janssen Research & Development, LLC | 75 | 2019-12-17 | 2026-07-30 |
| Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side Effects Enzalutamide - Prostatic Neoplasms, Castration-Resistant | Phase 4 | Completed | Radboud University Medical Center | 57 | 2019-05-30 | 2024-06-12 |
| The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients Rosuvastatin 20mg, surgical castration - Prostate Cancer Metastatic | Phase 4 | Completed | National Cancer Institute, Egypt | 70 | 2019-01-15 | 2021-03-02 |
| Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy. Ciprofloxacin, Trimethoprim/Sulfamethoxazole, Fosfomycin - Complication, Infection | Phase 4 | Completed | Radboud University Medical Center | 1538 | 2018-04-03 | 2022-05-10 |
| Study to Evaluate the Safety and Efficacy of Switching From Zoladex® Monthly or Quarterly, to Eligard® Semiannual. Leuprorelin Acetate (Eligard® 45 mg). - Prostate Cancer | Phase 4 | Completed | Zodiac Produtos Farmaceuticos S.A. | 48 | 2017-11-14 | 2022-03-31 |
| Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study Propofol, isoflurane, sevoflurane or desflurane - Cancer, Breast, Cancer Colorectal | Phase 4 | Completed | Peter MacCallum Cancer Centre, Australia | 169 | 2017-08-27 | 2022-06-09 |
| A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients Leuprolide - Prostate Cancer | Phase 4 | Completed | Astellas Pharma Singapore Pte. Ltd. | 107 | 2017-06-23 | 2024-11-26 |
| Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery Deep to Moderate NMB, Moderate to Deep NMB, Rocuronium - Cholecystitis, Endometriosis | Phase 4 | Completed | Stony Brook University | 79 | 2016-12-27 | 2020-04-08 |
| Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer Enzalutamide, Flutamide, Androgen deprivation therapy - Prostate Cancer | Phase 4 | Completed | Astellas Pharma Inc | 206 | 2016-11-02 | 2024-12-09 |
| 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases Pamidronate, Denosumab, Zoledronate - Breast Cancer, Prostate Cancer | Phase 4 | Completed | Ottawa Hospital Research Institute | 263 | 2016-08-01 | 2020-12-02 |
| A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer Degarelix - Prostate Cancer | Phase 4 | Completed | Ferring Pharmaceuticals | 230 | 2016-05-01 | 2021-12-15 |
| Clinical Trial to Examine Individual Pain Tolerance in the Use of Two Anesthetic Techniques to Perform Saturation Prostate Biopsy MIDAZOLAM, MEPIVACAÍNE, FENTANILE - Prostatic Cancer | Phase 4 | Completed | Complexo Hospitalario Universitario de A Coruña | 100 | 2016-04-01 | 2018-01-26 |
| Preoperative Brimonidine on IOP of Patients Undergoing RALP brimonidine tartrate 0.2%, Carboxymethylcellulose Eye Drops - Prostate Cancer | Phase 4 | Completed | University Health Network, Toronto | 26 | 2016-02-29 | 2018-09-27 |
| Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists Degarelix (LHRH antagonist), LHRH agonist, EndoPAT2000 - Prostatic Neoplasms, Cardiovascular Diseases | Phase 4 | Completed | Rabin Medical Center | 80 | 2015-08-01 | 2019-06-12 |
| Transperineal, MRI-guided, Prostate Biopsy Transperineal, MRI-guided, prostate biopsy, Transrectal prostate biopsy (TRB): - Prostate Cancer | Phase 4 | Completed | University Hospital, Strasbourg, France | 90 | 2015-05-01 | 2025-12-19 |
| Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer CABAZITAXEL XRP6258, PEG-G-CSF, Prednisolone - Prostate Cancer | Phase 4 | Completed | Sanofi | 21 | 2015-04-01 | 2017-01-24 |
| The Effect of Propofol Based Total Intravenous Anesthesia on Oxidative Stress and Nitric Oxide propofol, Desflurane - Prostate Cancer | Phase 4 | Completed | Yonsei University | 50 | 2014-05-01 | 2015-07-29 |
Showing 20 of 65. Sign in to see all of them.
Breast Neoplasms (6) · Neoplasms (5) · Pain (4) · Anxiety Disorders (2) · Melanoma (2) · Multiple Myeloma (2) · Neoplasm Metastasis (2) · Prostatic Hyperplasia (2) · Acromegaly (1) · Bone Diseases, Metabolic (1) · Bone Neoplasms (1) · Cardiovascular Diseases (1) · Cholecystitis (1) · Colonic Neoplasms (1)
Genital Diseases (65) · Genital Diseases, Male (65) · Genital Neoplasms, Male (65) · Male Urogenital Diseases (65) · Neoplasms by Site (65) · Urogenital Neoplasms (65) · Prostatic Diseases (64) · Urogenital Diseases (64) · Neoplasms (60) · Pathological Conditions, Signs and Symptoms (8) · Skin Diseases (7) · Skin and Connective Tissue Diseases (7) · Breast Diseases (6) · Digestive System Diseases (5) · Neoplasms by Histologic Type (5)
Zoledronic Acid (14) · Dutasteride (4) · Leuprolide (4) · luprolide acetate gel depot (4) · Triptorelin Pamoate (3) · bicalutamide (3) · enzalutamide (3) · Androgen Antagonists (2) · Ciprofloxacin (2) · Desflurane (2) · Prednisolone (2) · Prednisone (2) · Propofol (2) · acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide (2) · cabazitaxel (2)
Novartis Pharmaceuticals (9) · Novartis (4) · GlaxoSmithKline (3) · Sanofi (3) · Astellas Pharma Inc (2) · Radboud University Medical Center (2) · Yonsei University (2) · American Medical Systems (1) · Astellas Pharma Singapore Pte. Ltd. (1) · AstraZeneca (1) · Axogen Corporation (1) · Bay State Clinical Trials, Inc. (1) · Beth Israel Deaconess Medical Center (1) · Blue Earth Diagnostics (1) · Bucheon St. Mary's Hospital (1)
United States (21) · Canada (8) · Denmark (4) · Netherlands (4) · South Korea (4) · Spain (4) · Australia (3) · Brazil (3) · Finland (3) · France (3) · Germany (3) · Greece (3) · Italy (3) · Japan (3) · Belgium (2)
Anne Sophie P. Kancir, MD PhD (1) · Brian Helfand, M.D. (1) · Buys M Yvonne, MD FRCSC (1) · Byung Ha Chung, Medicine (1) · Carlos Hernandez, MD (1) · Colin McCartney, MD (1) · David Margel, MD, PhD (1) · Evangelos Liatsikos, MD (1) · Franklin M Chu, MD (1)
PMID 17724727, PMID 19143027, PMID 24354113, PMID 25627076, PMID 25988518, PMID 27286961, PMID 30028657, PMID 30224019, PMID 30300367, PMID 31329922, PMID 34068083, PMID 34350976, PMID 35280654, PMID 36419331, PMID 36480560, PMID 37101774, PMID 38485614, PMID 40389061, PMID 41729277, PMID 4723349
R01CA138627 (1)